Get the Stockscreener App
1.145
4.34%
-0.045
Therapeuticsmd Inc stock is traded at $1.145, with a volume of 32,983.
It is down -4.34% in the last 24 hours and up +6.16% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.19
Open:
$1.17
24h Volume:
32,983
Relative Volume:
0.20
Market Cap:
$13.25M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.1604
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-13.10%
1M Performance:
+6.16%
6M Performance:
-19.83%
1Y Performance:
-26.51%
1-Day Range:
$1.12
$1.19
1-Week Range:
$1.12
$1.3399
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.145 | 13.77M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
144.33 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.39 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.51 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.53 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recovery2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Can TherapeuticsMD Inc. stock weather global recession2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Trend analysis for TherapeuticsMD Inc. this week2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedWeekly Profit Analysis & Consistent Return Investment Signals - newser.com
How to manage a losing position in TherapeuticsMD Inc.Insider Buying & AI Based Buy/Sell Signal Reports - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stock2025 Technical Patterns & Precise Buy Zone Identification - newser.com
What MACD and RSI say about TherapeuticsMD Inc.July 2025 Update & Fast Gain Stock Trading Tips - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
Key metrics from TherapeuticsMD Inc.’s quarterly dataPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com
How to read the order book for TherapeuticsMD Inc.Weekly Trade Review & Daily Chart Pattern Signals - newser.com
How to build a dashboard for TherapeuticsMD Inc. stock2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Therapeuticsmd Inc Stock (TXMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
1.17%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):